- Home
- BDX
as 09-15-2025 4:00pm EST
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (27% of 2024 revenue) and BD Interventional (24%) account for the remainder. International revenue accounts for 43% of the company's business.
| Founded: | 1897 | Country: | United States |
| Employees: | N/A | City: | FRANKLIN LAKES |
| Market Cap: | 49.0B | IPO Year: | 1962 |
| Target Price: | $222.75 | AVG Volume (30 days): | 1.7M |
| Analyst Decision: | Buy | Number of Analysts: | 9 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 5.47 | EPS Growth: | 12.91 |
| 52 Week Low/High: | $163.33 - $251.99 | Next Earning Date: | 11-06-2025 |
| Revenue: | $21,386,000,000 | Revenue Growth: | 7.86% |
| Revenue Growth (this year): | 9.4% | Revenue Growth (next year): | 4.76% |
Stock Insider Trading Activity of Becton Dickinson and Company (BDX)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Fraser Claire | BDX | Director | Sep 10 '25 | Sell | $187.50 | 917 | $171,937.50 | 22,226 | |
| Feld Michael | BDX | EVP & President, Life Sciences | Aug 22 '25 | Sell | $197.99 | 57 | $11,285.43 | 8,360 | |
| HAYES GREGORY | BDX | N/A | Aug 11 '25 | Buy | $191.57 | 5,250 | $1,005,742.50 | 6,046 |
Latest Becton Dickinson and Company News
BDX Breaking Stock News: Dive into BDX Ticker-Specific Updates for Smart Investing
Zacks
5 days ago
Hologic's 2025 Outlook Improves on Strong Q3, Easing Tariff Headwinds
Barchart
10 days ago
Is Becton, Dickinson and Company Stock Underperforming the S&P 500?
Simply Wall St.
12 days ago
Becton, Dickinson and Company (NYSE:BDX) Shares Could Be 27% Above Their Intrinsic Value Estimate
PR Newswire
13 days ago
BD Expands Peripheral Artery Disease Awareness Efforts with 'Love Your Limbs' Community Screening Initiative
Insider Monkey
17 days ago
Becton, Dickinson and Company (BDX) Generated Lower-Than-Expected Revenue in Q2
Zacks
18 days ago
Are Options Traders Betting on a Big Move in Becton Dickinson Stock?
Zacks
18 days ago
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
Zacks
19 days ago
Here's Why Becton Dickinson (BDX) is a Strong Value Stock
Compare BDX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "BDX Becton Dickinson and Company - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.